Pneumocystis carinii derived from infected murine lung was found to be capable of limited growth in Vero African green monkey kidney cell cultures. The observed increase in the number of cyst forms was influenced by the ratio of cysts to host cells in the inocula, duration of passage, and formulation of the cell culture media. Maximum growth was achieved by inoculating 1.3 x 105 cysts per 75-cm2 flask containing about 2 x 107 Vero cells (cyst-to-cell ratio = 1:154) maintained on minimal essential medium supplemented with 2% fetal bovine serum. Under these conditions of culture, a 10.8-fold increase in cyst forms was observed during a 3-day passage interval, whereas only a 3.6-fold increase occurred during a 7-day passage in cell culture utilizing cyst-to-cell ratios ranging from 1:28 to 1:2,778.
Pneumocystis carinii pneumonitis was first recognized in the United States in 1956. Since that time, it has increased in prevalence, presumably because of the extended longevity of susceptible patients, i.e., those on immunosuppressive therapy and those with compromised immunity (2) .
The in vitro cultivation of P. carinii (5) and the elucidation of its morpholoy and host-parasite interrelationships by scanning electron microscopy (4) have been achieved only recently. Highly purified organisms grown in primary cell cultures have been effectively utilized in diagnostic and epidemiological studies of P.
carinii infection in both normal and immunosuppressed children (L. L. Pifer, W. T. Hughes, S. Stagno, and D. Woods, Pediatrics, in press). To date, P. carinii has been propagated in primary embryonic chick epithelial lung cell cultures (5), owl monkey kidney, baby hamster kidney, AV-3 (6), Vero, Chang liver, and MRC-5 cells (3).
The objective of this study was to quantitatively assess the growth rate of P. carinii in Vero cell cultures and to determine the potential usefulness of a permanent cell line in the production of purified P. carinii organisms for use in diagnostic and other investigative procedures.
MATERIALS AND METHODS P. carinii organisms derived from the cortisone acetate-treated Sprague-Dawley rats (1) were prepared and quantitated as previously described (5 FBS were routinely used in these studies. Growth media were discarded, and inocula in the range of 1.3 x 10i to 8.5 x 105 cysts per culture were applied to the monolayers in a volume of 1 to 2 ml of media. Cells and inocula were tested for the presence of mycoplasma and found to contain none. The inocula were allowed to absorb for 2 h at 370C, and the monolayers were then supplemented with fresh media and returned to the incubator. Ten microliters of media was removed from the cultures at daily intervals, and the cysts were quantified (5). Previously, this method of quantitation yielded coefficients of variation ranging from 0.7 to 1.6% for 1,459 and 2,047 cysts, respectively, in a volume of 10 jdl.
Monolayers were examined qualitatively on a daily basis for evidence of cytopathic effect. The cells were harvested by scraping with a rubber policeman at various times after infection, combined with the cysts in the supernatant, and concentrated by centrifugation before enumerating the total number of cysts per culture.
In one type of experiment utilizing Vero cultures, cysts in the culture supernatant were harvested by centrifugation and inoculated onto fresh monolayers every 24 h for 7 days. The parent monolayers in each instance were supplemented with fresh media, either MEM with 2% FBS or medium 199 with 10% FBS, and incubated for an additional 7 days. Ten-microliter samples were taken from each culture in each passage for 7 days, and the cysts were counted. This experiment was conducted to determine if fresh cells would enhance the yield of P. carinii from Vero cultures. 
RESULTS

